Balance Sheet
Accounts PayablesAccumulated ExpensesCommon EquityConvertible DebtLiabilities and Shareholders EquityLiabilities from Discontinued OperationsPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicale (MCLE) Common Equity (2020 - 2025)

Medicale (MCLE) has disclosed Common Equity for 6 consecutive years, with -$129416.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Common Equity fell 57.72% year-over-year to -$129416.0, compared with a TTM value of -$129416.0 through Jun 2025, down 57.72%, and an annual FY2024 reading of -$98933.0, down 142.96% over the prior year.
  • Common Equity was -$129416.0 for Q2 2025 at Medicale, down from -$123888.0 in the prior quarter.
  • Across five years, Common Equity topped out at $5108.0 in Q1 2021 and bottomed at -$129416.0 in Q2 2025.
  • Average Common Equity over 5 years is -$52195.3, with a median of -$40570.0 recorded in 2022.
  • Peak annual rise in Common Equity hit 56.23% in 2022, while the deepest fall reached 2135.62% in 2022.
  • Year by year, Common Equity stood at -$27051.0 in 2021, then soared by 56.23% to -$11841.0 in 2022, then crashed by 406.94% to -$60027.0 in 2023, then plummeted by 92.6% to -$115613.0 in 2024, then dropped by 11.94% to -$129416.0 in 2025.
  • Business Quant data shows Common Equity for MCLE at -$129416.0 in Q2 2025, -$123888.0 in Q1 2025, and -$115613.0 in Q4 2024.